News brief­ing: Sanofi ponies up more mon­ey to ex­pand pro­tein degra­da­tion col­lab with Nurix; Bio­gen fires shot at ...

5 years ago
News Briefing

Watch out, Pfiz­er: Affini­vax lands $226M in fund­ing to ad­vance Pre­vnar 13 ri­val as well as the rest of its pipeline

5 years ago
Financing

Alk­er­mes pro­motes from with­in to find new CFO and COO in re­bound ef­fort; Mod­er­na vet Robert Dol­s­ki joins Check­mate as ...

5 years ago
Peer Review

Iso­Plex­is scores big backer for per­son­al­ized pro­tein 'bar­codes' as Per­cep­tive jumps on board new fund­ing round

5 years ago
Financing

Af­ter ear­ly hic­cups in man­u­fac­tur­ing, Ad­verum out­lines plans for com­mer­cial gene ther­a­py plant in North Car­oli­na hub

5 years ago
Manufacturing

Nas­daq rings in its first biotech IPOs of 2021: a CAR-T spe­cial­ist from Chi­na, a can­cer port­fo­lio play, and a SPAC

5 years ago
Financing
China

FDA side­swipes Ne­oleukin with clin­i­cal hold on lead im­munother­a­py can­di­date, sends shares plum­met­ing

5 years ago
R&D
FDA+

DiCE gets its 'li­brary' card ready as it speeds de­vel­op­ment of DNA data­base-de­rived mol­e­cules with more in­vestor cash

5 years ago
Financing

Michael Ehlers is bet­ting $40M that an AI out­fit has fig­ured out how to beat the block­buster IL-2 chal­lenge

5 years ago
Startups

Chimerix places its bets on On­co­ceu­tic­s' dopamine an­tag­o­nist for rare brain can­cer in quest to sal­vage its im­age

5 years ago
Deals

Covid-19 roundup: Pfiz­er, BioN­Tech study sug­gest vac­cine works against vari­ants; Re­searchers say Sino­vac's vac­cine is ...

5 years ago
Coronavirus

Mer­ck KGaA snaps up Ger­man CD­MO in boost to mR­NA port­fo­lio — in­clud­ing for Covid-19

5 years ago
Deals
Manufacturing

FDA of­fers first thoughts on neu­rode­gen­er­a­tive dis­ease gene ther­a­pies

5 years ago
Cell/Gene Tx
FDA+

Mana joins the hec­tic fight against sol­id tu­mors with an ‘off-the-shelf’ can­di­date an­gling for an IND this year

5 years ago
Financing
Cell/Gene Tx

Sarep­ta gene ther­a­py for Duchenne mus­cu­lar dy­s­tro­phy fails on func­tion — rais­ing se­ri­ous ques­tions about all their ...

5 years ago
R&D

2020 brought a huge boom in health­care in­vest­ment. How big? SVB an­a­lysts have the record-break­ing an­swer

5 years ago
Financing

News brief­ing: Pfiz­er kick­starts PhI­II tri­al for DMD gene ther­a­py, out­rac­ing Sarep­ta; Teva's re­for­mu­lat­ed ...

5 years ago
News Briefing

Ki­ra and its com­ple­ment-tar­get in­hibitors plot run to the clin­ic with new in­vestor cash just months af­ter un­cloak­ing

5 years ago
Financing

Rick Klaus­ner fronts cash for his fun­gus out­fit LifeM­ine and brings on No­bel lau­re­ate to fur­ther push can­cer ...

5 years ago
Financing
Startups

Fu­ji­film's CD­MO arm plots mas­sive $2B plant in the US for broad range of ther­a­peu­tics

5 years ago
Outsourcing

Bio­phar­ma lead­ers con­demn mob vi­o­lence on Capi­tol Hill, look­ing to close Trump's chaot­ic chap­ter in Amer­i­can his­to­ry

5 years ago
Pharma

Der­mi­ra vets li­cense back can­di­dates from Eli Lil­ly to launch their own up­start

5 years ago
Startups
Deals

Look­ing to solve the sol­id tu­mor puz­zle box, Caris­ma aims to take 'CAR-M' ground­break­er in­to ear­ly-stage tri­al

5 years ago
Financing

DBV re­struc­tur­ing claims 200 jobs as it beats out a path to­ward peanut patch OK

5 years ago
People
First page Previous page 758759760761762763764 Next page Last page
A service from the Financial Times